Product Image

Omega-3 2400 mg

Gaspari Nutrition
4.7
★ ★ ★ ★ ★
(102 ratings)
EPA (Eicosapentaenoic Acid) 960 mg
Fish Oil 2400 mg
DHA 720 mg
Protein (unspecified) 1 Gram(s)
Product Image
Score80
Substantial, clearly stated EPA and DHA amounts are the main strength. Quality confidence is limited by missing source, form, purification, and antioxidant details.
How scoring works
Quantity:60 Softgel(s) • (30 servings)
Goals:
Cardiovascular Support
Heart Health
Vision Support
Anti-Inflammatory Support
Mental Focus

Score 80

Substantial, clearly stated EPA and DHA amounts are the main strength. Quality confidence is limited by missing source, form, purification, and antioxidant details.
How scoring works
$24.99($0.83 per serving)
iHerb
$ 24.99
Report prices

Analysis

Clearly quantified EPA and DHA make the active dose easy to assess. The EPA-forward balance supports cardiovascular and inflammatory pathways, while the substantial DHA amount adds relevance for retinal and brain structure.

The formula is deep rather than broad, so it does not cover vascular tone, carotenoids, or acute focus pathways. Omega-3 fats are better suited to ongoing structural and inflammatory support than an immediate mental-performance effect.

Fish species, molecular form, purification, and oxidation protection are not described in the supplied data. Those gaps matter more in a concentrated oil because potency alone does not establish freshness or contaminant control.

Who is it for
  • Adults seeking a concentrated EPA and DHA formula
  • People focused on heart, vision, or inflammatory support
Best for
  • High-dose marine omega-3 intake
  • A clearly quantified EPA-and-DHA serving

Pros

  • EPA and DHA are individually quantified
  • Substantial combined marine omega-3 amount
  • EPA-forward profile with meaningful DHA

Cons

  • Molecular form is not identified
  • Fish source and purification details are missing
  • No antioxidant stabilizer is listed

Warnings

  • Fish-derived oil can trigger an allergic reaction in people with fish allergy. The substantial EPA and DHA intake warrants caution with anticoagulant or antiplatelet medicines because bleeding tendency may increase.

Nutrient quality

81 Highest impact

The concentrated serving supplies substantial EPA and DHA in a focused formula. The undisclosed molecular form and lack of stated oxidation protection are the main quality limitations.

.

Ingredient transparency

84 Highest impact

Fish oil, EPA, and DHA amounts are individually disclosed with no proprietary blend. Molecular form, purification, usage directions, and non-active ingredients are not fully shown.

.

Customer satisfaction

69 High impact

The average rating is strong and the review count is reasonably informative. No review text was supplied to assess repeated complaints or whether experiences match the intended uses.

.

Value for money

86 Highest impact

The concentrated active dose provides good value per useful serving. A focused formula supports the price, though missing quality controls keep the value assessment from being stronger.

.
Report analysis

Goals

Cardiovascular Support
Cardiovascular Support
Impact
Highest effect
A Goal FitA+ Strength of SupportC+ CoverageA+ Formula Quality
Fish Oil · 2400 mg

Clearly disclosed EPA and DHA provide strong support for triglyceride management and systemic inflammatory balance. The formula is focused rather than broad and does not directly support nitric oxide, homocysteine, or heart-energy pathways.

The combined EPA and DHA amount is substantial and represents most of the fish-oil concentrate. Fish-derived oil can trigger an allergic reaction in people with fish allergy, and high-dose use warrants attention with anticoagulant or antiplatelet therapy.

Study evidence
Fish Oil Supportive 185 studies
Heart Health
Heart Health
Impact
Highest effect
A Goal FitA+ Strength of SupportC+ CoverageA+ Formula Quality
EPA (Eicosapentaenoic Acid) · 960 mg

Clearly disclosed EPA and DHA provide direct support for triglyceride management and cardiovascular inflammation. The combined amount is substantial enough to make this a focused and evidence-based heart-health option.

The formula concentrates on one major lipid pathway rather than vascular tone, cardiac energy, or homocysteine support. EPA and DHA can increase bleeding tendency when combined with anticoagulants or antiplatelet medicines, especially at higher total daily omega-3 intakes.

Study evidence
Vision Support
Vision Support
Impact
Highest effect
A- Goal FitA Strength of SupportC+ CoverageA+ Formula Quality
EPA (Eicosapentaenoic Acid) · 960 mg

High DHA and EPA amounts strongly support retinal membrane structure and ocular-surface balance. The formula has excellent lipid depth but no carotenoids or antioxidant minerals for wider eye protection.

Both fatty acids are individually quantified at substantial amounts. The supplied data does not identify their chemical form, fish source, or oxidation-quality controls.

Study evidence
Anti-Inflammatory Support
Anti-Inflammatory Support
Impact
Highest effect
A Goal FitB Strength of SupportB- CoverageA+ Formula Quality
Fish Oil · 2400 mg

Clearly disclosed EPA and DHA provide a strong active amount for inflammation-resolving pathways. Human evidence supports these fatty acids for inflammatory markers and selected inflammatory conditions.

The high concentration gives the single-oil strategy excellent depth. Missing molecular form, fish source, purification details, antioxidant protection, and independent testing reduce quality confidence.

Study evidence
Fish Oil Supportive 68 studies
Mental Focus
Mental Focus
Impact
High effect
C Goal FitB+ Strength of SupportD CoverageB+ Formula Quality

EPA and DHA provide long-term support for brain structure and a healthy inflammatory balance, but they are not direct acute focus enhancers. The disclosed amounts are substantial and may support the conditions needed for steady cognition over time.

The formula does not address alertness, neurotransmitter production, or stress resilience with dedicated focus ingredients. Exact fatty-acid amounts are helpful, although the oil form and oxidation-quality details are not provided.

Study evidence

Ingredients

IngredientAmount per serving
Calories
35 Calorie(s)
Calories from Fat
25 Calorie(s)
Total Fat
3 Gram(s)
Saturated Fat
1 Gram(s)
Polyunsaturated Fat
1 Gram(s)
Monounsaturated Fat
0.5 Gram(s)
Cholesterol
25 mg
Carbohydrates
1 Gram(s)
Protein
1 Gram(s)
Fish Oil concentrate
2400 mg
Eicosapentaenoic Acid
960 mg
Docosahexaenoic Acid
720 mg
Adults 18–50
Report overview
EPA (Eicosapentaenoic Acid) · 960 mg OverallScore63
D Active Ingredient Quality & BioavailabilityB- Dose, Safety & Label TransparencyB+ Value

The molecular form is unspecified; ePA density is moderately concentrated, and no protective antioxidant is listed. The serving provides a high therapeutic EPA amount with more EPA than DHA but not a strongly EPA-centric ratio. No purification or third-party verification is shown, while normalized cost is favorable.

View ingredientView products
Fish Oil · 2400 mg OverallScore50
F Active Ingredient Quality & BioavailabilityB Dose, Safety & Label TransparencyB+ Value

The oil lacks molecular-form, purification, and source details. EPA and DHA are clearly disclosed at an effective dose and high concentration. Active-dose value is good, but no antioxidant stabilizer is shown.

View ingredientView products
DHA · 720 mg OverallScore42
F Active Ingredient Quality & BioavailabilityD Dose, Safety & Label TransparencyC Value

The DHA chemical form is not identified, leaving bioavailability uncertain. The 720 mg DHA serving reaches a high-potency amount. No protective antioxidant is listed, and generic fish oil lacks explicit third-party purity verification.

View ingredientView products
Loading alternative details
86 Performance

Omega-3 Triglyceride Fish Oil 1100 mg

NATURELO Premium Supplements
Clearer active dosing, source quality, or formula focus improves on a concentrated fish oil with substantial disclosed EPA and DHA but limited oil-quality details. A concentrated triglyceride-form, EPA-led serving has clear fatty-acid amounts and molecular-distillation disclosure, with only smaller sourcing and testing gaps.
87 Performance

Omega-3

Solgar
Clearer active dosing, source quality, or formula focus improves on a concentrated fish oil with substantial disclosed EPA and DHA but limited oil-quality details. High, clearly disclosed EPA and DHA amounts provide substantial active depth, while mixed tocopherols aid oxidation control.
86 Performance

Purified & Clear Omega 3 Fish Oil 1000 mg

Doctor's Best
Clearer active dosing, source quality, or formula focus improves on a concentrated fish oil with substantial disclosed EPA and DHA but limited oil-quality details. A substantial, clearly separated EPA and DHA serving provides strong potency, although the ethyl-ester form absorbs less readily than triglyceride oil.
76 Budget

Omega-3 Fish Oil 1000 mg Lemon

Natrol
It lowers recurring cost while retaining the central fatty-acid pathway of a concentrated fish oil with substantial disclosed EPA and DHA but limited oil-quality details. EPA and DHA are clearly listed at a basic maintenance amount, but the oil form, species, oxidation protection, purification, and testing are not disclosed.
79 Budget

Omega-3 Fish Oil with Vitamin D 1000 mg Lemon Flavored

Swanson
It lowers recurring cost while retaining the central fatty-acid pathway of a concentrated fish oil with substantial disclosed EPA and DHA but limited oil-quality details. Vitamin D3 adds compatible breadth to clearly quantified but modest EPA and DHA, while oil-form and quality details remain unknown.
70 Budget

Omega-3 Salmon Oil

Bluebonnet
It lowers recurring cost while retaining the central fatty-acid pathway of a concentrated fish oil with substantial disclosed EPA and DHA but limited oil-quality details. EPA and DHA are clearly listed, but the active amount is modest and dilute within the oil, with limited quality documentation.
84 Value

Mega EPA/DHA

Life Extension
Relevant active coverage at no higher supplied serving cost improves practical value over a concentrated fish oil with substantial disclosed EPA and DHA but limited oil-quality details. A substantial EPA-and-DHA dose with natural vitamin E provides focused depth, while molecular form, fish species, purification, and testing are not supplied.
81 Value

Omega JYM

JYM Supplement Science
Relevant active coverage at no higher supplied serving cost improves practical value over a concentrated fish oil with substantial disclosed EPA and DHA but limited oil-quality details. Substantial equal EPA and DHA amounts plus DPA create a deep marine-fatty-acid profile, while source, form, oxidation protection, and testing remain undisclosed.
84 Value

Alaska Wild Fish Oil Mega Omega-3

21st Century
Relevant active coverage at no higher supplied serving cost improves practical value over a concentrated fish oil with substantial disclosed EPA and DHA but limited oil-quality details. The concentrated EPA-forward profile provides substantial active delivery, but molecular form, antioxidant protection, fish species, and independent testing are absent.
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Dose-dependent effects of fish oil on cardio-metabolic biomarkers in healthy middle-aged and elderly Chinese people: a double-blind randomized controlled trial.
    Song J; Hu M; Li C; Yang B; Ding Q; Wang C; Mao L · Food & function · 2018
    Randomized trial201 participantsAnti-Inflammatory Support forFish Oil
  2. Eicosapentaenoic acid supplementation alleviates pruritus, enhances skin moisture, and mitigates depression in maintenance hemodialysis patients.
    Lin YL; Wang CL; Chiang TI · Frontiers in nephrology · 2024
    Randomized trial60 participantsAnti-Inflammatory Support forFish Oil
  3. Lowering effects of fish oil supplementation on proinflammatory markers in hypertension: results from a randomized controlled trial.
    Yang B; Ren XL; Li ZH; Shi MQ; Ding F; Su KP; Guo XJ; Li D · Food & function · 2020
    Randomized trial77 participantsAnti-Inflammatory Support forFish Oil
  4. The effects of ω-3 fish oil emulsion-based parenteral nutrition plus combination treatment for acute paraquat poisoning.
    Meng Z; Dong Y; Gao H; Yao D; Gong Y; Meng Q; Zheng T; Cui X; Su X; Tian Y · The Journal of international medical research · 2019
    Randomized trial174 participantsAnti-Inflammatory Support forFish Oil
  5. Effects of Omega-3 Fatty Acid Intake in Patients Undergoing Dialysis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Liu R; Jiang J; Fu Z; Liu C; Yao L; Quan H · Journal of the American Nutrition Association · 2022
    Meta-analysis49 studies pooledAnti-Inflammatory Support forFish Oil
  6. Marine Omega-3 Supplementation and Cardiovascular Disease: An Updated Meta-Analysis of 13 Randomized Controlled Trials Involving 127 477 Participants.
    Hu Y; Hu FB; Manson JE · Journal of the American Heart Association · 2020
    Meta-analysis127,477 participants13 studies pooledCardiovascular Support forFish Oil
  7. Impact of omega-3 fatty acids on hypertriglyceridemia, lipidomics, and gut microbiome in patients with type 2 diabetes.
    Lu J; Liu R; Ren H; Wang S; Hu C; Shi Z; Li M; Liu W; Wan Q; Su Q; Li Q; Zheng H; Qu S; Yang F; Ji H; Lin H; Qi H; Wu X; Wu K; Chen Y; Xu Y; Xu M; Wang T; Zheng J; Ning G; Zheng R; Bi Y; Zhong H; Wang W · Med (New York, N.Y.) · 2025
    Randomized trial309 participantsCardiovascular Support forFish Oil
  8. A systematic review of fish-oil supplements for the prevention and treatment of hypertension.
    Campbell F; Dickinson HO; Critchley JA; Ford GA; Bradburn M · European journal of preventive cardiology · 2013
    Meta-analysis1,524 participants17 studies pooledCardiovascular Support forFish Oil
  9. Effects of fish oil-derived fatty acids on suboptimal cardiovascular health: A multicenter, randomized, double-blind, placebo-controlled trial.
    Zeng Q; Dong SY; Liu YP; Fu J; Shuai P; Zhao ZM; Li TX · Nutrition, metabolism, and cardiovascular diseases : NMCD · 2017
    Randomized trial422 participantsCardiovascular Support forFish Oil
  10. Effect of High-Dose Marine Omega-3 Fatty Acids on Atherosclerosis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.
    Sekikawa A; Cui C; Sugiyama D; Fabio A; Harris WS; Zhang X · Nutrients · 2020
    Meta-analysis6 studies pooledCardiovascular Support forFish Oil
  11. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis.
    Yokoyama M; Origasa H; Matsuzaki M; Matsuzawa Y; Saito Y; Ishikawa Y; Oikawa S; Sasaki J; Hishida H; Itakura H; Kita T; Kitabatake A; Nakaya N; Sakata T; Shimada K; Shirato K; Japan EPA lipid intervention study (JELIS) Investigators · Lancet (London, England) · 2007
    Randomized trial18,645 participantsHeart Health forEPA (Eicosapentaenoic Acid)
  12. Effects of EPA on coronary artery disease in hypercholesterolemic patients with multiple risk factors: sub-analysis of primary prevention cases from the Japan EPA Lipid Intervention Study (JELIS).
    Saito Y; Yokoyama M; Origasa H; Matsuzaki M; Matsuzawa Y; Ishikawa Y; Oikawa S; Sasaki J; Hishida H; Itakura H; Kita T; Kitabatake A; Nakaya N; Sakata T; Shimada K; Shirato K; JELIS Investigators, Japan · Atherosclerosis · 2008
    Randomized trial14,981 participantsHeart Health forEPA (Eicosapentaenoic Acid)
  13. Effects of omega-3 fatty acids on coronary revascularization and cardiovascular events: a meta-analysis.
    Dinu M; Sofi F; Lotti S; Colombini B; Mattioli AV; Catapano AL; Casula M; Baragetti A; Wong ND; Steg PG; Ambrosio G · European journal of preventive cardiology · 2024
    Meta-analysis134,144 participants18 studies pooledHeart Health forEPA (Eicosapentaenoic Acid)
  14. Incremental effects of eicosapentaenoic acid on cardiovascular events in statin-treated patients with coronary artery disease.
    Matsuzaki M; Yokoyama M; Saito Y; Origasa H; Ishikawa Y; Oikawa S; Sasaki J; Hishida H; Itakura H; Kita T; Kitabatake A; Nakaya N; Sakata T; Shimada K; Shirato K; Matsuzawa Y; JELIS Investigators · Circulation journal : official journal of the Japanese Circulation Society · 2009
    Randomized trialHeart Health forEPA (Eicosapentaenoic Acid)
  15. Omega-3 Fatty Acids for the Management of Hypertriglyceridemia: A Science Advisory From the American Heart Association.
    Skulas-Ray AC; Wilson PWF; Harris WS; Brinton EA; Kris-Etherton PM; Richter CK; Jacobson TA; Engler MB; Miller M; Robinson JG; Blum CB; Rodriguez-Leyva D; de Ferranti SD; Welty FK; American Heart Association Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Lifestyle and Cardiometabolic Health; Council on Cardiovascular Disease in the Young; Council on Cardiovascular and Stroke Nursing; and Council on Clinical Cardiology · Circulation · 2020
    OtherHeart Health forEPA (Eicosapentaenoic Acid)
  16. The influence of n-3 polyunsaturated fatty acids on cognitive function in individuals without dementia: a systematic review and dose-response meta-analysis.
    Suh SW; Lim E; Burm SY; Lee H; Bae JB; Han JW; Kim KW · BMC medicine · 2024
    Meta-analysis9,660 participants24 studies pooledMental Focus forEPA (Eicosapentaenoic Acid)
  17. EPA supplementation improves teacher-rated behaviour and oppositional symptoms in children with ADHD.
    Gustafsson PA; Birberg-Thornberg U; Duchén K; Landgren M; Malmberg K; Pelling H; Strandvik B; Karlsson T · Acta paediatrica (Oslo, Norway : 1992) · 2011
    Randomized trial92 participantsMental Focus forEPA (Eicosapentaenoic Acid)
  18. Docosahexaenoic Acid (DHA) and Eicosapentaenoic Acid (EPA)-Should They Be Mandatory Supplements in Pregnancy?
    Amza M; Haj Hamoud B; Sima RM; Dinu MD; Gorecki GP; Popescu M; Gică N; Poenaru MO; Pleș L · Biomedicines · 2024
    Narrative reviewMental Focus forEPA (Eicosapentaenoic Acid)
  19. Supplementation with oil rich in eicosapentaenoic acid, but not in docosahexaenoic acid, improves global cognitive function in healthy, young adults: results from randomized controlled trials.
    Patan MJ; Kennedy DO; Husberg C; Hustvedt SO; Calder PC; Khan J; Forster J; Jackson PA · The American journal of clinical nutrition · 2021
    Randomized trial310 participantsMental Focus forEPA (Eicosapentaenoic Acid)
  20. Dietary omega-3 LCPUFA intake in the prevention of neovascular age-related macular degeneration: a systematic review and meta-analysis.
    Meng XT; Shi YY; Hong-Yan Z · Nutricion hospitalaria · 2022
    Meta-analysis5 studies pooledVision Support forEPA (Eicosapentaenoic Acid)
  21. Dietary omega-3 polyunsaturated fatty acids and fish intake and risk of age-related macular degeneration.
    Jiang H; Shi X; Fan Y; Wang D; Li B; Zhou J; Pei C; Ma L · Clinical nutrition (Edinburgh, Scotland) · 2022
    Meta-analysis21 studies pooledVision Support forEPA (Eicosapentaenoic Acid)
  22. Dietary fatty acid intake, plasma fatty acid levels, and the risk of age-related macular degeneration (AMD): a dose-response meta-analysis of prospective cohort studies.
    Zhong Y; Wang K; Jiang L; Wang J; Zhang X; Xu J; Yao K · European journal of nutrition · 2021
    Meta-analysis167,581 participants11 studies pooledVision Support forEPA (Eicosapentaenoic Acid)
  23. Dietary ω-3 fatty acid and fish intake and incident age-related macular degeneration in women.
    Christen WG; Schaumberg DA; Glynn RJ; Buring JE · Archives of ophthalmology (Chicago, Ill. : 1960) · 2011
    Cohort study38,022 participantsVision Support forEPA (Eicosapentaenoic Acid)
  24. Can Omega-3 Fatty Acids Serve as a Preventive Strategy for Age-Related Macular Degeneration? A Systematic Review and Meta-Analysis.
    Chen KY; Chan HC; Chan CM · The Journal of nutrition · 2026
    Meta-analysis18 studies pooledVision Support forEPA (Eicosapentaenoic Acid)